Forty-nine Americans were diagnosed with Powassan virus disease in 2023, the highest annual total since national reporting began in 2004 and a jump from the previous record set just one year earlier. The virus, carried by black-legged ticks concentrated in the Northeast and Upper Midwest, can pass from tick to human in as little as 15 minutes of attachment. In severe cases, Powassan triggers brain swelling and can kill within days, leaving almost no window for the kind of quick tick removal that protects against slower-transmitting pathogens like Lyme disease.
Record Powassan case count and what drove it
The 2023 total of 49 confirmed and probable cases broke a record that had stood for less than 12 months, according to the CDC’s arboviral surveillance summary covering nationally notifiable infections. That report states explicitly that Powassan virus disease case reports “were the highest since reporting began in 2004” and that they “increased from the previous record high in 2022.” The back-to-back records suggest a trend rather than a single anomalous year.
Powassan virus disease became a nationally notifiable condition in 2004, meaning state and territorial health departments report cases to the CDC using standardized case definitions. The agency’s Powassan data portal explains this reporting pipeline and provides the ArboNET-derived figures that underpin year-over-year tracking. Because the system depends on clinical recognition and laboratory confirmation, the true number of infections is almost certainly higher than the reported figure. Mild or asymptomatic cases rarely prompt the testing needed to enter the surveillance record, and even severe cases can be misclassified as other causes of encephalitis when clinicians are unfamiliar with Powassan testing.
One hypothesis that researchers have not yet formally tested in published literature is whether the counties reporting Powassan cases in 2023 show measurable expansion of Ixodes scapularis habitat compared with the 2018 through 2022 ArboNET baselines. The CDC’s historic case maps allow county-level views of distribution over time, and cross-referencing those maps against land-cover datasets could reveal whether warming temperatures and shifting vegetation patterns are pushing the black-legged tick into new territory. No published study has completed that specific comparison, but the consecutive record years make the question urgent for entomologists and public health planners tracking tick-borne disease risk.
Other factors may be contributing as well. Outdoor recreation surged in many parts of the country in recent years, potentially increasing human-tick encounters in forested and brushy areas where black-legged ticks thrive. At the same time, public awareness campaigns have focused heavily on Lyme disease, sometimes without mentioning Powassan or other viral infections carried by the same tick species. That imbalance could mean that people adopt behaviors calibrated to Lyme’s slower transmission window-such as same-day tick checks-without realizing that Powassan requires more aggressive prevention to avoid infection.
Fifteen minutes: the transmission speed that separates Powassan from Lyme
The most alarming feature of Powassan virus is the speed at which it moves from tick to host. Laboratory experiments published in the Journal of Virology demonstrated that transmission from infected Ixodes scapularis ticks to mice occurred after roughly 15 minutes of feeding. That finding has been echoed across multiple reviews. A scholarly synthesis in the journal Viruses, published through MDPI, notes that the minimum attachment time for successful Powassan transmission can be as little as 15 minutes, citing foundational work by researchers Gregory Ebel and Laura Kramer.
The New York State Department of Health reinforces this timeline in its public fact sheet, warning that, unlike other tick-borne diseases, a tick can transmit Powassan virus in as little as 15 minutes. A separate peer-reviewed overview in Frontiers in Public Health reaches the same conclusion, describing infection after approximately 15 minutes of attachment. By contrast, the Borrelia burgdorferi bacterium that causes Lyme disease typically requires 36 to 48 hours of attachment before transmission succeeds, giving people time to find and remove a feeding tick before they become infected.
That difference has direct consequences for anyone spending time outdoors in endemic areas. Standard guidance to shower and perform a tick check within two hours of coming indoors may reduce Lyme risk, but it offers far less protection against Powassan. A tick that attaches to a hiker’s ankle at the trailhead can deliver the virus before the hiker reaches the parking lot. Permethrin-treated clothing, EPA-registered repellents applied before exposure, and strategies that keep ticks off skin and clothing-such as tucking pants into socks and staying on cleared trails-become the primary line of defense, because post-exposure removal alone cannot reliably prevent infection.
Once Powassan virus enters the body, there is no specific antiviral treatment. Care is supportive, focusing on managing brain swelling, seizures, and respiratory compromise in an intensive care setting when encephalitis develops. That reality gives prevention outsized importance. For clinicians, it also raises the stakes for early recognition: unexplained fever, headache, confusion, or seizures in a patient with recent tick exposure in the Northeast or Upper Midwest should prompt consideration of Powassan alongside more familiar diagnoses like Lyme neuroborreliosis or West Nile virus.
Gaps in Powassan data that shape the 2026 tick season
Several critical questions remain unanswered heading into the 2026 tick season. The CDC’s surveillance summaries for 2023 provide case counts but do not break out fatality rates or hospitalization numbers specific to that record year. Older clinical literature estimates that roughly 10 percent of severe Powassan encephalitis cases are fatal and about half of survivors experience lasting neurological problems, but whether those ratios held during the 2023 surge is not yet documented in published data. Without outcome-level reporting, clinicians and patients lack a clear picture of how dangerous the current pattern of infections actually is.
The geographic drivers behind the consecutive records also remain poorly characterized. Official notifiable-disease summaries do not include primary data on climate variables, deer population density, small-mammal reservoir abundance, or land-use change, all of which influence tick ecology. As a result, public health agencies can describe where human cases are occurring but cannot easily say why some counties have seen increases while neighboring jurisdictions have not. That uncertainty complicates decisions about where to concentrate limited resources for tick surveillance, public education, and clinician outreach.
Another major gap is the lack of standardized, active surveillance for Powassan virus in ticks themselves. Many state laboratories test ticks for Borrelia burgdorferi and sometimes for other bacterial pathogens, but viral testing is more technically demanding and costly. Without routine screening of field-collected ticks, it is difficult to know whether human cases are rising because more people are being bitten, because a higher proportion of ticks are infected, or both. Each scenario would call for a different mix of interventions, from habitat management to targeted messaging for high-risk groups like hunters, forestry workers, and outdoor guides.
Diagnostic limitations further cloud the picture. Powassan testing is not as widely available as Lyme serology, and turnaround times can be slow. In some regions, clinicians must send specimens to reference laboratories or to the CDC, discouraging testing in borderline cases. Patients with milder illness may never be tested at all, leading to underestimation of the true infection burden and biasing the known caseload toward the sickest individuals. That bias, in turn, may inflate perceived fatality rates while obscuring how often the virus causes only mild or subclinical disease.
For now, these data gaps mean that communities in Powassan-endemic regions must prepare for the 2026 tick season with imperfect information. The consecutive record years in 2022 and 2023 indicate that the threat is no longer hypothetical, even if the precise drivers are not fully mapped. Public health agencies can act on what is already clear: Powassan virus is present, it can be transmitted in a matter of minutes, and severe outcomes are possible. Expanded clinician education, clearer public messaging that distinguishes Powassan from Lyme, and investments in tick and wildlife surveillance would all help narrow the uncertainties before the next set of case counts arrives.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
